Evid Based Nurs 11:52 doi:10.1136/ebn.11.2.52
  • Treatment

Primary prevention with pravastatin for 5 years continued to prevent coronary events in the next 10 years

I Ford

Dr I Ford, University of Glasgow, Glasgow, UK;


In middle-aged men with hypercholesterolaemia and no history of myocardial infarction (MI), does 5 years of treatment with pravastatin have long-term benefits for prevention of coronary heart disease (CHD)?



post-trial follow-up of a randomised, placebo-controlled trial (West of Scotland Coronary Prevention Study [WOSCOPS]).


unclear allocation concealment.


blinded during the trial period {clinicians, patients, data collectors, and outcome adjudication committees}.*

Follow-up period:

original trial follow-up was 5 years; this study followed up surviving patients (96%) for 10 more years.


{coronary screening clinics in the UK}.*


6595 men {45–64 years of age}* (mean age 55 y) with no history of MI and low-density lipoprotein cholesterol concentrations ⩾155 mg/dl (4.01 mmol/l) on 2 occasions.


pravastatin, 40 …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article